Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Nanomedicine Market Expected to Be in 2029?

In recent years, there has been significant expansion in the nanomedicine market size. Projected to increase from $331.61 billion in 2024 to $375.87 billion in 2025, the compound annual growth rate (CAGR) is anticipated to be 13.3%. Factors contributing to the marked growth throughout the historical period include a deeper comprehension of molecular biology, rising occurrences of chronic ailment, the need for precise drug delivery systems, the broadening of nanoparticle imaging technologies, and the increasing aging population.

The expansion of the nanomedicine market is anticipated to accelerate dramatically in the forthcoming years. It is projected to surge to “$676.38 billion in 2029 with a compound annual growth rate (CAGR) of 15.8%. The surge during the forecasted period is due to the ongoing advancements in nanotechnology research, increased funding for nanomedicine R&D, growing emphasis on custom-tailored medicine, extensive use of nanomedicine in cancer care, and the incorporation of nanomedicine in treatments for infectious diseases. Key trends guiding the forecasted period include the creation of multipurpose nanoparticles for therapeutic and imaging purposes, focus on nanoparticle-induced diagnostics and imaging agents, the use of nanomedicine in regenerative medicine, increasing prevalence of nanomedicine in targeted treatments for neurological conditions, and collaborations and partnerships in nanomedicine research and commercialization.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5344&type=smp

What Are The Contributors To Demand In The Nanomedicine Market?

The escalating incidence of multifaceted and chronic ailments worldwide is anticipated to boost the nanomedicine market’s growth in the predicted timeframe. Chronic disease treatment, including health conditions like cardiovascular disorders, diabetes, cancer, dementia, among others, is increasingly utilizing nanomedicine to expedite drug metabolism in the body. For example, the International Federation of Alzheimer’s Associations, Alzheimer’s Disease International, noted that global dementia sufferers exceeded 50 million, a number estimated to double every 20 years, forecasting to touch 80 million by 2030 and 152 million by 2050. Additionally, it is estimated that the global cancer burden will soar, with new cases expected to reach 28.4 million by 2040. Such growing chronic disease burdens are likely to drive the need for effective nanomedicine-based therapeutic treatments, consequently contributing to the nanomedicine market’s expansion.

What Segmentation Categories Are Included In The Nanomedicine Market Analysis?

The nanomedicine market covered in this report is segmented –

1) By Type: Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Other Types

2) By Modality: Diagnostics, Treatments

3) By Application: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Other Applications

Subsegments:

1) By Nanoparticles: Lipid-Based Nanoparticles, Polymeric Nanoparticles, Metallic Nanoparticles, Ceramic Nanoparticles

2) By Nanoshells: Gold Nanoshells, Silver Nanoshells, Silica Nanoshells

3) By Nanotubes: Carbon Nanotubes (CNTs), Polymer Nanotubes

4) By Nanodevices: Nanosensors, Nanorobots, Nanoscale Imaging Devices

5) By Other Types: Dendrimers, Quantum Dots, Nanocarriers

Which Trends Are Redefining The Future Landscape Of The Nanomedicine Industry?

Significant corporations in the nanomedicine sector are harnessing the potential of cutting-edge products like the dynapro zetastar to boost their market revenues. This unique device brings together dynamic and static light scattering alongside dynamic and electrophoretic light scattering measurements (DLS/SLS/ELS). For instance, in September 2023, the Waters Corporation, a US-based firm known for its analytical laboratory devices and equipment, unveiled the dynapro zetastar which is engineered for nanoparticle analysis. The zetastar lends precision to the formulation of intricate biologics by converging multiple light scattering methodologies, streamlining data capture, autonomously evaluating data validity, and amplifying the sensitivity and velocity of measurements while leveraging exceptionally minimal sample volumes. The exclusive flow cell design of the zetastar device lends itself to linkage with an autosampler, thereby substantially augmenting lab productivity and efficacy by facilitating numerous unmonitored measurements that can be executed over multiple hours or even an entire night.

Who Are The Top-Ranked Companies In The Nanomedicine Market Today?

Major companies operating in the nanomedicine market include Pfizer Inc., Ablynx NV, Amgen Inc., Arrowhead Research Inc., Bio-Gate AG, Celgene Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences Inc., Merck AG, Nanospectra Biosciences, Nanotherapeutics Inc., NanoViricides Inc, Novartis AG, Sanofi S. A., Abraxis Bioscience Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., AuraSense Therapeutics LLC, BIND Therapeutics Inc., Camurus AB, Cerulean Pharma Inc., CytImmune Sciences, Fujifilm Holdings, Nanobiosym Inc., Nanobiotix SA, Nanogen Inc., Nanoparticle BioChem Inc., Nanospective Inc., Nanosphere Health Sciences Inc., Nanosys Inc., PerkinElmer Inc., Selecta Biosciences Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

How Is Nanomedicine Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the nanomedicine market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5344&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model